Skip to main content
. 2016 Sep 25;22(3):319–326. doi: 10.3350/cmh.2016.0045

Figure 1.

Figure 1.

Incidence of hepatocellular carcinoma (HCC) in chronic hepatitis B patients treated with nucleos(t)ide analogues. Data from studies with treated patients and untreated controls included in a systematic review15. VR, virological remission; NVR, No virological response; VBTH:, virological breakthrough.